Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
for applying living therapeutic materias. The PhD thesis will be embedded in the Leibniz Science Campus on Living Therapeutic Materials (https://www.lsclifemat.de ), an interdisciplinary consortium aiming
-
Working Title PhD MSE - Research Assistant Location Edinburg, Texas College College of Engineering and Computer Science Department College of Engineering and Computer Science / Mechanical Engineering
-
-matter physics, and materials science. Our research encompasses three research areas of new approaches in precision synthesis of PCL (A), PCLs’ properties and functions (B), and Experimental and
-
-matter physics, and materials science. Our research encompasses three research areas of new approaches in precision synthesis of PCL (A), PCLs’ properties and functions (B), and Experimental and
-
, condensed-matter physics, and materials science. Our research encompasses three research areas of new approaches in precision synthesis of PCL (A), PCLs’ properties and functions (B), and Experimental and
-
, and energy solutions. By integrating electrochemistry with advanced materials and engineering, the unit delivers pioneering solutions with real-world impact. Led by Prof. María Cuartero (ERC Fellow) and
-
Are you interested in developing computational tools to understand the detailed mechanical behaviour of multi-phase materials? Then this PhD position at Chalmers University of Technology might be
-
Organization (RTO) active in the fields of materials, environment and IT. By transforming scientific knowledge into technologies, smart data and tools, LIST empowers citizens in their choices, public authorities
-
and electrochemical devices, by employing advanced experimental and theoretical methods in an interdisciplinary approach bridging synthetic chemistry, condensed-matter physics, and materials science
-
rhabdomyosarcoma), fragmented data from multiple small series has hampered global elementary understanding of metastasis biology and - therefore – targeted therapy development. It remains unresolved – and is